TargetMol

Embusartan

Product Code:
 
TAR-T31619
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31619-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31619-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31619-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Embusartan (BAY 10-6734) is a potent, orally active angiotensin II receptor antagonist used as an antihypertensive agent.
CAS:
156001-18-2
Formula:
C25H24FN5O3
Molecular Weight:
461.497
Purity:
0.98
SMILES:
CCCCc1cc(cc(=O)n1Cc1ccc(cc1F)-c1ccccc1-c1nnn[nH]1)C(=O)OC

References

1. Wang JM, Tan J, Leenen FH. Central nervous system blockade by peripheral administration of AT1 receptor blockers. J Cardiovasc Pharmacol. 2003 Apr;41(4):593-9. PubMed PMID: 12658061. 2. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA. Sympatho-inhibitory properties of various AT1 receptor antagonists. J Hypertens Suppl. 2002 Jun;20(5):S3-11. PubMed PMID: 12184061. 3. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J Hypertens. 2001 Dec;19(12):2241-50. PubMed PMID: 11725169. 4. Zhang J, Leenen FH. Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium. Can J Physiol Pharmacol. 2001 Oct;79(10):861-7. Erratum in: Can J Physiol Pharmacol 2001 Dec;79(12):1045. PubMed PMID: 11697745.